Pages that link to "Q33935283"

The following pages link to Cellular delivery of antisense oligonucleotides (Q33935283):

Displaying 43 items.

• Modulation of the activity of Bcl-2 in Waldenstrom's macroglobulinemia using antisense oligonucleotides (Q28201765) (← links)
• Pharmacokinetics and biodistribution of novel aptamer compositions (Q31141055) (← links)
• Treatments for choroidal and retinal neovascularization: a focus on oligonucleotide therapy and delivery for the regulation of gene function. (Q33211168) (← links)
• PNA oligomers as tools for specific modulation of gene expression. (Q34241510) (← links)
• Uptake and antifungal activity of oligonucleotides in Candida albicans (Q34760610) (← links)
• Improvement of DNA transfection with cationic liposomes. (Q34835807) (← links)
• Optimizing the delivery systems of chimeric RNA.DNA oligonucleotides (Q35005702) (← links)
• Cytoplasmic delivery and nuclear targeting of synthetic macromolecules (Q35078380) (← links)
• Effect of Steric Constraint at the γ-Backbone Position on the Conformations and Hybridization Properties of PNAs (Q35110193) (← links)
• Applications of triple-stranded nucleic acid structures to DNA purification, detection and analysis (Q35183658) (← links)
• Strategies for identifying genes that play a role in spinal cord regeneration. (Q35613644) (← links)
• Glycotargeting to improve cellular delivery efficiency of nucleic acids (Q36724850) (← links)
• Synthesis of conformationally preorganized and cell-permeable guanidine-based gamma-peptide nucleic acids (gammaGPNAs). (Q37115025) (← links)
• Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics. (Q37321859) (← links)
• Electron spin resonance spectroscopy in drug delivery (Q37352715) (← links)
• Surface-engineered dendrimers: a solution for toxicity issues (Q37372870) (← links)
• Nanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNA. (Q37444136) (← links)
• Nano and microtechnologies for the delivery of oligonucleotides with gene silencing properties (Q37585046) (← links)
• Beyond oncology--application of HPMA copolymers in non-cancerous diseases. (Q37631869) (← links)
• Canonical and non-canonical barriers facing antimiR cancer therapeutics (Q38112723) (← links)
• Quantum mechanical studies of DNA and LNA. (Q38405255) (← links)
• Antisense oligonucleotide delivery to cancer cell lines for the treatment of different cancer types (Q38816182) (← links)
• Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549. (Q39185508) (← links)
• Lipid Nanovectors to Deliver RNA Oligonucleotides in Cancer (Q39196485) (← links)
• Down-regulation of MDM2 and activation of p53 in human cancer cells by antisense 9-aminoacridine-PNA (peptide nucleic acid) conjugates (Q40068515) (← links)
• Antisense 2'-Deoxy, 2'-Fluroarabino Nucleic Acids (2'F-ANAs) Oligonucleotides: In Vitro Gymnotic Silencers of Gene Expression Whose Potency Is Enhanced by Fatty Acids (Q41111748) (← links)
• The cytoplasmic escape and nuclear accumulation of endocytosed and microinjected HPMA copolymers and a basic kinetic study in Hep G2 cells (Q42064010) (← links)
• Interplay of polyethyleneimine molecular weight and oligonucleotide backbone chemistry in the dynamics of antisense activity (Q42093781) (← links)
• In vitro characterization of two novel biodegradable vectors for the delivery of radiolabeled antisense oligonucleotides. (Q42762222) (← links)
• Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres (Q43248722) (← links)
• Inhibition of HIV-1 in cell culture by oligonucleotide-loaded nanoparticles (Q43654284) (← links)
• Spectrophotometric determination of polyethylenimine in the presence of an oligonucleotide for the characterization of controlled release formulations (Q44263349) (← links)
• Chitosan-coated liposomes for intracellular oligonucleotides delivery: characteristics and cell uptake behavior (Q44867756) (← links)
• The solution synthesis of antisense oligonucleotide-peptide conjugates directly linked via phosphoramide bond by using a fragment coupling approach (Q45208898) (← links)
• The role of antisense oligonucleotides in the wave of genomic information (Q46260338) (← links)
• Charged dendrimers under the action of AC electric fields: breathing characteristics of molecular size, polarizations, and ion distributions (Q47403170) (← links)
• Alginate/poly-L-lysine microparticles for the intestinal delivery of antisense oligonucleotides. (Q52956485) (← links)
• Characterization of alginate/poly-L-lysine particles as antisense oligonucleotide carriers. (Q52957219) (← links)
• Physicochemical characterization of protamine-phosphorothioate nanoparticles (Q58200477) (← links)
• Comparison of two methods of encapsulation of an oligonucleotide into poly(D,L-lactic acid) particles (Q73701613) (← links)
• Albumin nanoparticles as carriers for a phosphodiester oligonucleotide (Q74693408) (← links)
• Delivery of Macromolecules into Cytosol using Liposomes Containing Hemolysin (Q79281035) (← links)
• Selective Small Molecule Recognition of RNA Base Pairs (Q89388055) (← links)